HBOT Conversations:
Join us for interviews with researchers, practitioners, industry experts, and patients to share their stories, successes, and expertise relative to hyperbaric oxygen therapy
Subscribe. Join the discussion. Share the hope.
Listen to or Watch the HBOT Conversations Podcast
Listen to the HBOT Converstations podcast by downloading it from your favorite podcasting platform or scroll down and watch an episode here on the HBOT News website:
Watch the HBOT Conversations Podcast
Subscribe Now, It’s Free !
Recent HBOT News
Effects of hyperbaric oxygen on motor function in children with cerebral palsy.
Abstract: We conducted a randomized, double-blind, controlled clinical trial to determine whether hyperbaric oxygen (HBO) improves gross motor function in children with cerebral palsy. Forty-nine children aged 3 to 8 years with spastic cerebral palsy were randomized...
Hyperbaric oxygen in the treatment of childhood autism: a randomised controlled trial.
Abstract: Promising results with hyperbaric therapy for children with autism have been reported, but most involved the use of only mild pressure with oxygen supplementation. To date, there has been no randomised, blinded trial of 100% oxygen administered at hyperbaric...
Clinical Trial – Saliva, Hyperbaric Oxygen Therapy, & Gland Function: A Prospective Study
The purpose of this study is to determine if Hyperbaric Oxygen (HBO) therapy improves
salivary gland function in previously head-and-neck irradiated patients. The following will
be evaluated: salivary a-amylase, IGF-1, Thrombospondin-1, and VEGF-A concentrations, resting
and stimulated salivary flow rate and pH, and salivary buffering capacity. Demographic data,
past medical/surgical histories, social history and habits, risk factors, medication list,
nutritional status, stage and location of tumor treated, dose/duration of radiation, and time
elapsed since radiation treatment will be reviewed and recorded. Subjects will complete a
quality of life questionnaire, describe (presence/absence) dry mouth symptoms prior to HBO
therapy, and provide current A1c level, or submit to a finger stick. The following groups
will be evaluated: 1. Head-and-neck irradiated subjects with ORN (indicating HBO therapy) 2.
Subjects with other conditions indicating HBO therapy (positive control), and 3.
Head-and-neck irradiated subjects without ORN (negative control). Subjects will include 78
males or females, 18 years old and over. In total, participation will last 22 weeks.